Julie Papanek Grant's Net Worth
Estimate Recalculated Nov 11, 2024 01:52PM EST
Who is Julie Papanek Grant
Julie Papanek Grant does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., and Protagonist Therapeutics, Inc.
SEC CIK
Julie Papanek Grant's CIK is 0001673237
Past Insider Trading and Trends
2016 was Julie Papanek Grant's most active year for acquiring shares with 1 total transactions. Julie Papanek Grant's most active month to acquire stocks was the month of April. 2021 saw Julie Papanek Grant paying a total of $0.00 for 63,000 shares, this is the most they've acquired in one year.
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
